OConnell Daniel Joseph
Chief Executive Officer · 9 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-01-22 | ABOS | Acumen Pharmaceuticals, Inc. | Sale | 2,689 | $1.88 | $5,065.54 | filing |
| 2026-01-21 | ABOS | Acumen Pharmaceuticals, Inc. | Sale | 9,346 | $1.81 | $16,927.48 | filing |
| 2026-01-20 | ABOS | Acumen Pharmaceuticals, Inc. | Award | 299,800 | $0.00 | $0.00 | filing |
| 2026-01-12 | ABOS | Acumen Pharmaceuticals, Inc. | Sale | 5,388 | $1.73 | $9,306.69 | filing |
| 2026-01-09 | ABOS | Acumen Pharmaceuticals, Inc. | Sale | 12,941 | $1.76 | $22,831.81 | filing |
| 2026-01-08 | ABOS | Acumen Pharmaceuticals, Inc. | Sale | 8,143 | $1.82 | $14,815.37 | filing |
| 2026-01-07 | ABOS | Acumen Pharmaceuticals, Inc. | Sale | 37,755 | $1.99 | $74,981.43 | filing |
| 2026-01-06 | ABOS | Acumen Pharmaceuticals, Inc. | Sale | 5,102 | $1.97 | $10,031.55 | filing |
| 2026-01-05 | ABOS | Acumen Pharmaceuticals, Inc. | Sale | 4,649 | $1.97 | $9,163.18 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.